EV Biologics, Inc. (YECO)

OTCMKTS: YECO · Delayed Price · USD
0.980 -0.010 (-1.01%)
Jan 18, 2022 10:58 AM - Market closed
Market Cap40.22M
Revenue (ttm)9.51M
Net Income (ttm)-7.43M
Shares Out41.04M
EPS (ttm)-0.23
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume425
Open0.989
Previous Close0.990
Day's Range0.980 - 0.989
52-Week Range0.801 - 6.370
Beta-2.20
Analystsn/a
Price Targetn/a
Earnings Daten/a

About YECO

EV Biologics, Inc., a biotechnology company, engages in the commercial development of extracellular vesicles (EVs) as biological modalities for diagnostics and therapeutics. It is involved in developing vaccines, therapeutics, and cures based on its proprietary multifunctional EV platform. The company also focuses on developing human mesenchymal and other stem cell, and cell-derived products to market in the cosmetic and biopharmaceutical spaces. The company was formerly known as Yulong Eco-Materials Limited and changed its name to EV Biologics...

IndustryBiotechnology
Founded2011
CEOYulong Zhu
Employees284
Stock ExchangeOTCMKTS
Ticker SymbolYECO
Full Company Profile

Financial Performance

Financial Statements

News

EV Biologics Updates on FINRA

NASHVILLE, TN / ACCESSWIRE / January 18, 2022 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its submitted FINRA applications for name change and NFT dividend ...

4 hours ago - Accesswire

EV Biologics Updates on NFT Dividend

NASHVILLE, TN / ACCESSWIRE / November 12, 2021 / EV Biologics Corp, (OTC PINK:YECO), today updated shareholders with further details about its NFT dividend. The Company is still awaiting approval from F...

2 months ago - Accesswire

EV Biologics Signs Listing Agreement With INX

NASHVILLE, TN / ACCESSWIRE / November 11, 2021 / EV Biologics Corp, ("the Company"), OTC PINK:YECO, today confirmed that it has signed an agreement to list its common stock on the INX Securities ATS, a ...

2 months ago - Accesswire

EV Biologics Chief Medical Officer Publication on COVID-19 & Exosomes

NASHVILLE, TN / ACCESSWIRE / October 28, 2021 / EV Biologics Corp, OTC Pink:YECO, today updated shareholders about a recent publication authored by its Chief Medical Officer, Dr. Jason Sanders. This rev...

2 months ago - Accesswire

EV Biologics Updates on NFT Minting

NASHVILLE, TN / ACCESSWIRE / September 28, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT and minting progress. Our NFT team has been minting the ...

3 months ago - Accesswire

EV Biologics Updates on NFT Warrant Dividend Distribution

NASHVILLE, TN / ACCESSWIRE / August 30, 2021 / EV Biologics Corp, (OTC Pink:YECO), today updated shareholders with further details about its NFT Warrant Dividend distribution. The Company is currently f...

4 months ago - Accesswire

EV Biologics Briefs Shareholders on Market Cap Peer Comparison

NASHVILLE, TN / ACCESSWIRE / August 12, 2021 / EV Biologics Corp, OTC Pink:YECO, today briefed shareholders on its current value compared to other public biotechnology companies in its peer group. Pleas...

5 months ago - Accesswire

EV Biologics NFT Dividend Information

NASHVILLE, TN / ACCESSWIRE / August 9, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT Warrant Dividend. Attached is a preliminary image from the 3...

5 months ago - Accesswire

EV Biologics NFT Dividend Warrant Date

NASHVILLE, TN / ACCESSWIRE / July 30, 2021 / EV Biologics Corp., OTC PINK:YECO, today confirmed for share holders its NFT Warrant Dividend shareholders-of-record date. YECO's shareholders-of-record on J...

5 months ago - Accesswire

EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services

NASHVILLE, TN / ACCESSWIRE / July 28, 2021 / EV Biologics Corp, OTC PINK:YECO today announced that it has signed an agreement with Lonza Cell Bio Services to implement a custom cell isolation in prepara...

5 months ago - Accesswire

EV Biologics Unveils NFT Dividend Warrant

NASHVILLE, TN / ACCESSWIRE / July 26, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend Warrant. The Company will distribute one (1) Warrant for every 100 shares...

5 months ago - Accesswire

EV Biologics Signs LOI with Lonza Cell & Gene Therapy

NASHVILLE, TN / ACCESSWIRE / July 22, 2021 / EV Biologics Corp., (OTC PINK:YECO) today announced that it has signed a Letter of Intent (LOI) with Lonza Cell & Gene Therapy for Process Development and Ga...

5 months ago - Accesswire

EV Biologics NFT Dividend Update

NASHVILLE, TN / ACCESSWIRE / July 19, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders about its NFT dividend. On July 14, 2021 the Company announced a dividend of 1 NFT for every 100...

5 months ago - Accesswire

EV Biologics Announces NFT Dividend

CHEYENNE, WY / ACCESSWIRE / July 14, 2021 / EV Biologics Corp, OTC PINK:YECO, today announced that it will distribute a dividend of one (1) Non-Fungible Token (NFT) for every 100 shares of YECO common s...

6 months ago - Accesswire

EV Biologics is now Pink Current

CHEYENNE, WY / ACCESSWIRE / June 14, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has completed all its filings on OTC Markets and is now Pink Current. Being current and Penny Stock ...

7 months ago - Accesswire

EV Biologics Updates Shareholders on Name and Symbol Change

CHEYENNE, WY / ACCESSWIRE / May 19, 2021 / EV Biologics Corp., OTC PINK:YECO, is taking this opportunity to update our shareholders and other investors concerning the status of our name change submissio...

7 months ago - Accesswire

EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research

NASHVILLE, TN / ACCESSWIRE / April 8, 2021 / EV Biologics Corp (OTC PINK:YECO) today announced that it has signed a director's loan agreement to secure funding of up to $5 million to start generation of...

9 months ago - Accesswire